322 related articles for article (PubMed ID: 35181718)
1. P2X
Peikert A; König S; Suchanek D; Rofa K; Schäfer I; Dimanski D; Karnbrock L; Bulatova K; Engelmann J; Hoppe N; Wadle C; Heidt T; Albrecht P; von Garlen S; Härdtner C; Hilgendorf I; Wolf D; von Zur Mühlen C; Bode C; Zirlik A; Duerschmied D; Merz J; Stachon P
Sci Rep; 2022 Feb; 12(1):2801. PubMed ID: 35181718
[TBL] [Abstract][Full Text] [Related]
2. Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice.
Stachon P; Geis S; Peikert A; Heidenreich A; Michel NA; Ünal F; Hoppe N; Dufner B; Schulte L; Marchini T; Cicko S; Ayata K; Zech A; Wolf D; Hilgendorf I; Willecke F; Reinöhl J; von Zur Mühlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1577-86. PubMed ID: 27339459
[TBL] [Abstract][Full Text] [Related]
3. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
4. P2X
Stachon P; Heidenreich A; Merz J; Hilgendorf I; Wolf D; Willecke F; von Garlen S; Albrecht P; Härdtner C; Ehrat N; Hoppe N; Reinöhl J; von Zur Mühlen C; Bode C; Idzko M; Zirlik A
Circulation; 2017 Jun; 135(25):2524-2533. PubMed ID: 28377486
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
8. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135
[TBL] [Abstract][Full Text] [Related]
9. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
[TBL] [Abstract][Full Text] [Related]
10. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
Mulholland M; Depuydt MAC; Jakobsson G; Ljungcrantz I; Grentzmann A; To F; Bengtsson E; Jaensson Gyllenbäck E; Grönberg C; Rattik S; Liberg D; Schiopu A; Björkbacka H; Kuiper J; Bot I; Slütter B; Engelbertsen D
Cardiovasc Res; 2024 May; 120(6):581-595. PubMed ID: 38563353
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
Fukuda D; Nishimoto S; Aini K; Tanaka A; Nishiguchi T; Kim-Kaneyama JR; Lei XF; Masuda K; Naruto T; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Imoto I; Akasaka T; Shimabukuro M; Sata M
J Am Heart Assoc; 2019 Apr; 8(7):e010860. PubMed ID: 30905257
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nuñez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E
Nature; 2010 Apr; 464(7293):1357-61. PubMed ID: 20428172
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
Paramel Varghese G; Folkersen L; Strawbridge RJ; Halvorsen B; Yndestad A; Ranheim T; Krohg-Sørensen K; Skjelland M; Espevik T; Aukrust P; Lengquist M; Hedin U; Jansson JH; Fransén K; Hansson GK; Eriksson P; Sirsjö A
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207962
[TBL] [Abstract][Full Text] [Related]
15. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages.
Espada S; Stavik B; Holm S; Sagen EL; Bjerkeli V; Skjelland M; Dahl TB; Espevik T; Kanse S; Sandset PM; Skretting G; Halvorsen B
Biochem Biophys Res Commun; 2017 Sep; 491(2):442-448. PubMed ID: 28712870
[TBL] [Abstract][Full Text] [Related]
17. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
[TBL] [Abstract][Full Text] [Related]
19. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
[TBL] [Abstract][Full Text] [Related]
20. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
